• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

增强适体的药代动力学:使用刷状聚合物偶联适体在体内靶向AXL

Enhancing the Pharmacokinetics of Aptamers: Targeting AXL In Vivo Using a Bottlebrush Polymer-Conjugated Aptamer.

作者信息

Sun Tingyu, Lin Jiachen, Xue Chenyang, Wang Yuyan, Chen Peiru, Wei Yun, Xu Guobin, Sidonia Anais, Nenopoulos Chris, Tashkandi Hossam, Shen Caroline, Wang Allison, Wang Alex, Zhang Ke

机构信息

Department of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts, 02115, USA.

Department of Biochemistry, Northeastern University, Boston, Massachusetts, 02115, USA.

出版信息

Adv Healthc Mater. 2025 Jun 26:e2405083. doi: 10.1002/adhm.202405083.

DOI:10.1002/adhm.202405083
PMID:40566927
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12343208/
Abstract

The overexpression of receptor tyrosine kinase AXL receptor tyrosine kinase (AXL) is linked to acquired drug resistance in cancer treatments. Aptamers, acting as antibody surrogates, have been envisioned as potential inhibitors for AXL. However, aptamers face difficult pharmacological challenges including rapid degradation and clearance. Herein, a phosphodiester-backboned bottlebrush polymer is reported as a carrier for conjugated aptamers. Termed polymer-augmented conjugates of DNA (pacDNA), the conjugate improves aptamer specificity in vivo, prolongs blood retention, and enhances overall aptamer bioactivity. Treatment with pacDNA in AXL-overexpressing cell lines significantly inhibits AXL phosphorylation, resulting in reduced cancer cell migration and invasion. In a non-small cell lung cancer xenograft model (NCI-H1299), pacDNA treatment leads to single-agent reduction in tumor growth. These results highlight the potential of bottlebrush polymers in the field of aptamer therapeutics.

摘要

受体酪氨酸激酶AXL(AXL受体酪氨酸激酶)的过表达与癌症治疗中获得性耐药有关。适体作为抗体替代物,被视为AXL的潜在抑制剂。然而,适体面临着包括快速降解和清除在内的艰巨药理学挑战。在此,报道了一种磷酸二酯主链的刷状聚合物作为共轭适体的载体。这种共轭物被称为聚合物增强DNA共轭物(pacDNA),它提高了适体在体内的特异性,延长了血液滞留时间,并增强了整体适体生物活性。在AXL过表达细胞系中用pacDNA处理可显著抑制AXL磷酸化,从而减少癌细胞的迁移和侵袭。在非小细胞肺癌异种移植模型(NCI-H1299)中,pacDNA处理导致肿瘤生长单药减少。这些结果突出了刷状聚合物在适体治疗领域的潜力。

相似文献

1
Enhancing the Pharmacokinetics of Aptamers: Targeting AXL In Vivo Using a Bottlebrush Polymer-Conjugated Aptamer.增强适体的药代动力学:使用刷状聚合物偶联适体在体内靶向AXL
Adv Healthc Mater. 2025 Jun 26:e2405083. doi: 10.1002/adhm.202405083.
2
AXL enhances the self-renewal of cancer stem-like cells and Osimertinib chemoresistance by regulating SCD1 in non-small cell lung cancer.AXL通过调节非小细胞肺癌中的SCD1来增强癌症干细胞样细胞的自我更新能力和奥希替尼化疗耐药性。
Biochem Pharmacol. 2025 Oct;240:117067. doi: 10.1016/j.bcp.2025.117067. Epub 2025 Jun 23.
3
A Cyclized Bivalent Aptamer-Based Protein Degrader Targeting Receptor Tyrosine Kinases Overcomes Resistance to Inhibitors in Lung Cancer.一种基于环化双价适体的靶向受体酪氨酸激酶的蛋白质降解剂克服了肺癌对抑制剂的耐药性。
ACS Nano. 2025 Aug 12;19(31):28171-28185. doi: 10.1021/acsnano.5c03120. Epub 2025 Jul 29.
4
Targeting both wild-type EGFR and its drug-resistant mutants with erlotinib-aptamer conjugates.使用厄洛替尼适配体偶联物靶向野生型表皮生长因子受体(EGFR)及其耐药突变体。
Eur J Med Chem. 2025 Oct 15;296:117871. doi: 10.1016/j.ejmech.2025.117871. Epub 2025 Jun 14.
5
Targeting AXL Inhibits the Growth and Metastasis of Prostate Cancer in Bone.靶向AXL可抑制前列腺癌在骨中的生长和转移。
Clin Cancer Res. 2025 Apr 1;31(7):1346-1358. doi: 10.1158/1078-0432.CCR-24-3028.
6
Intrinsic resistance to ROS1 inhibition in a patient with CD74-ROS1 mediated by AXL overexpression.患者 CD74-ROS1 融合基因阳性,通过 AXL 过表达介导对 ROS1 抑制剂产生内在耐药。
Thorac Cancer. 2023 Nov;14(33):3259-3265. doi: 10.1111/1759-7714.15116. Epub 2023 Sep 19.
7
Xg-13, a derivate of marine natural product, exhibits anti-angiogenesis ability in hepatocellular carcinoma via inhibiting Axl signaling pathway.Xg-13是一种海洋天然产物衍生物,通过抑制Axl信号通路在肝细胞癌中展现出抗血管生成能力。
Biochem Pharmacol. 2025 Sep;239:117040. doi: 10.1016/j.bcp.2025.117040. Epub 2025 Jun 6.
8
Axl inhibitor-mediated reprogramming of the myeloid compartment of the tumor microenvironment is influenced by prior targeted therapy treatment.Axl抑制剂介导的肿瘤微环境髓样区室重编程受先前靶向治疗的影响。
Front Immunol. 2025 Jun 5;16:1601420. doi: 10.3389/fimmu.2025.1601420. eCollection 2025.
9
AXL degradation in combination with EGFR-TKI can delay and overcome acquired resistance in human non-small cell lung cancer cells.AXL 降解与 EGFR-TKI 联合使用可延缓并克服人类非小细胞肺癌细胞获得性耐药。
Cell Death Dis. 2019 May 1;10(5):361. doi: 10.1038/s41419-019-1601-6.
10
AXL promotes inflammatory breast cancer progression by regulating immunosuppressive macrophage polarization.AXL通过调节免疫抑制性巨噬细胞极化促进炎性乳腺癌进展。
Breast Cancer Res. 2025 May 6;27(1):70. doi: 10.1186/s13058-025-02015-8.

本文引用的文献

1
Bottlebrush Polymers with Sequence-Controlled Backbones for Enhanced Oligonucleotide Delivery.具有序列可控主链的瓶刷状聚合物用于增强寡核苷酸递送
J Am Chem Soc. 2024 Dec 18;146(50):34763-34770. doi: 10.1021/jacs.4c13285. Epub 2024 Nov 27.
2
Targeting the Skin: The Study of a Bottlebrush Polymer-Antisense Oligonucleotide Conjugate in a Psoriasis Mouse Model.靶向皮肤:在银屑病小鼠模型中研究瓶刷聚合物-反义寡核苷酸缀合物。
Small. 2024 Nov;20(47):e2403949. doi: 10.1002/smll.202403949. Epub 2024 Aug 14.
3
Enabling safer, more potent oligonucleotide therapeutics with bottlebrush polymer conjugates.
用瓶刷聚合物缀合物实现更安全、更有效的寡核苷酸治疗。
J Control Release. 2024 Feb;366:44-51. doi: 10.1016/j.jconrel.2023.12.035. Epub 2023 Dec 29.
4
Inhibition of AXL receptor tyrosine kinase enhances brown adipose tissue functionality in mice.抑制 AXL 受体酪氨酸激酶可增强小鼠棕色脂肪组织的功能。
Nat Commun. 2023 Jul 13;14(1):4162. doi: 10.1038/s41467-023-39715-8.
5
AXL in cancer: a modulator of drug resistance and therapeutic target.AXL 在癌症中的作用:耐药性的调节剂和治疗靶点。
J Exp Clin Cancer Res. 2023 Jun 16;42(1):148. doi: 10.1186/s13046-023-02726-w.
6
A mechanistic study on the cellular uptake, intracellular trafficking, and antisense gene regulation of bottlebrush polymer-conjugated oligonucleotides.关于刷状聚合物共轭寡核苷酸的细胞摄取、细胞内运输及反义基因调控的机制研究
RSC Chem Biol. 2022 Nov 8;4(2):138-145. doi: 10.1039/d2cb00149g. eCollection 2023 Feb 8.
7
A Long-Circulating Vector for Aptamers Based upon Polyphosphodiester-Backboned Molecular Brushes.基于聚磷酸二酯骨架分子刷的适体长循环载体。
Angew Chem Int Ed Engl. 2022 Oct 10;61(41):e202204576. doi: 10.1002/anie.202204576. Epub 2022 Sep 6.
8
Maximizing TLR9 Activation in Cancer Immunotherapy with Dual-Adjuvanted Spherical Nucleic Acids.双佐剂球形核酸在癌症免疫治疗中最大化 TLR9 激活。
Nano Lett. 2022 May 25;22(10):4058-4066. doi: 10.1021/acs.nanolett.2c00723. Epub 2022 May 6.
9
AXL targeting restores PD-1 blockade sensitivity of mutant NSCLC through expansion of TCF1 CD8 T cells.AXL 靶向治疗通过扩增 TCF1+CD8+T 细胞恢复 PD-1 阻断敏感性的 突变型非小细胞肺癌。
Cell Rep Med. 2022 Mar 15;3(3):100554. doi: 10.1016/j.xcrm.2022.100554.
10
AXL Receptor Tyrosine Kinase as a Promising Therapeutic Target Directing Multiple Aspects of Cancer Progression and Metastasis.AXL受体酪氨酸激酶作为一个有前景的治疗靶点,主导癌症进展和转移的多个方面。
Cancers (Basel). 2022 Jan 18;14(3):466. doi: 10.3390/cancers14030466.